AEON Biopharma Analyst Ratings
AEON Biopharma Analyst Ratings
While ratings are subjective and will change, the latest AEON Biopharma (AEON) rating was a initiated with a price target of $0.00 to $18.00. The current price AEON Biopharma (AEON) is trading at is $4.34, which is within the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/18/2023 | 314.75% | HC Wainwright & Co. | → $18 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目标价格变动 | 评级变动 | 之前/当前的评级 |
|---|---|---|---|---|---|
| 08/18/2023 | 314.75% | HC Wainwright & Co. | → 18 美元 | 启动覆盖开启 | → 购买 |
What is the target price for AEON Biopharma (AEON)?
永旺生物制药（AEON）的目标价格是多少？
The latest price target for AEON Biopharma (AMEX: AEON) was reported by HC Wainwright & Co. on August 18, 2023. The analyst firm set a price target for $18.00 expecting AEON to rise to within 12 months (a possible 314.75% upside). 1 analyst firms have reported ratings in the last year.
HC Wainwright & Co. 于2023年8月18日公布了永旺生物制药（美国证券交易所股票代码：AEON）的最新目标股价。该分析公司将目标股价定为18.00美元，预计永旺将在12个月内上涨至314.75％（可能上涨314.75％）。去年有1家分析公司公布了评级。
What is the most recent analyst rating for AEON Biopharma (AEON)?
AEON Biopharma（AEON）的最新分析师评级是多少？
The latest analyst rating for AEON Biopharma (AMEX: AEON) was provided by HC Wainwright & Co., and AEON Biopharma initiated their buy rating.
AEON Biopharma（美国证券交易所股票代码：AEON）的最新分析师评级由HC Wainwright & Co. 提供，AEON Biopharma启动了买入评级。
When is the next analyst rating going to be posted or updated for AEON Biopharma (AEON)?
永旺生物药业（AEON）的下一份分析师评级何时发布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of AEON Biopharma, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for AEON Biopharma was filed on August 18, 2023 so you should expect the next rating to be made available sometime around August 18, 2024.
分析师在进行了广泛的研究后得出了股票评级，包括阅读公开财务报表、与永旺生物制药的高管和客户交谈以及听取财报电话会议。大多数分析师每三个月进行一次评级，因此每家公司每年应获得4个评级。永旺生物制药的最新评级是在2023年8月18日提交的，因此您应该预计下一个评级将在2024年8月18日左右公布。
Is the Analyst Rating AEON Biopharma (AEON) correct?
分析师对永旺生物制药（AEON）的评级是否正确？
While ratings are subjective and will change, the latest AEON Biopharma (AEON) rating was a initiated with a price target of $0.00 to $18.00. The current price AEON Biopharma (AEON) is trading at is $4.34, which is within the analyst's predicted range.
虽然评级是主观的，并且会发生变化，但最新的永旺生物制药（AEON）评级最初的目标价为0.00美元至18.00美元。永旺生物制药（AEON）目前的交易价格为4.34美元，在分析师的预测区间内。
